Data / Federal rules / 2025-14037
Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
The Drug Enforcement Administration published this final rule in the Federal Register on July 25, 2025. It took effect on July 26, 2025.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated July 26, 2023, DEA temporarily placed these five substances in schedule I of the Controlled Substances Act. This temporary order will extend the temporary scheduling of five designer benzodiazepines for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.
Key facts
- Document number
- 2025-14037
- Type
- Final rule
- Action
- Temporary scheduling order; extension
- Agency
- Justice Department; Drug Enforcement Administration
- Published
- July 25, 2025
- Takes effect
- July 26, 2025
- Dates
- This temporary scheduling order, which extends schedule I control of five specific substances covered by an order (88 FR 48112, July 26, 2023), is effective July 26, 2025, and expires on July 26, 2026. If DEA publishes a final rule making this scheduling action permanent, this order will expire on the effective date of that rule, if the effective date is earlier than July 26, 2026.
- Docket
- Docket No. DEA-989
- Code of Federal Regulations
- 21 CFR 1308
- Pages
- 3
Other documents from the Drug Enforcement Administration
Everything from the Drug Enforcement Administration · Published in July 2025
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.